Story perspectives

GLP-1 Drugs: Breakthroughs and Risks in Diabetes Treatment

10/13/2025

41 7

Summary

Story summary

GLP-1 drugs, including semaglutide, treat type 2 diabetes and obesity by mimicking the natural hormone GLP-1.
The medications promote insulin production and reduce appetite to improve metabolic control.
Side effects include gastrointestinal issues and potential long-term risks such as pancreatitis and eye diseases.
Research continues into their uses for neurodegenerative disorders and addiction, while experts urge integrating pharmacological and behavioral strategies to support long-term health after discontinuation.

1 of 1

Story summary

GLP-1 drugs, including semaglutide, treat type 2 diabetes and obesity by mimicking the natural hormone GLP-1.
The medications promote insulin production and reduce appetite to improve metabolic control.
Side effects include gastrointestinal issues and potential long-term risks such as pancreatitis and eye diseases.
Research continues into their uses for neurodegenerative disorders and addiction, while experts urge integrating pharmacological and behavioral strategies to support long-term health after discontinuation.